Filter
2293
Featured
320
67
Language
Document type
838
392
331
163
135
110
101
71
43
40
34
23
12
Countries
161
133
93
90
89
78
61
59
50
48
47
45
43
40
36
36
34
33
33
28
28
28
27
25
24
23
23
19
19
18
18
18
17
16
16
14
13
12
12
12
12
12
11
11
11
10
10
10
10
10
9
9
9
8
8
8
8
8
7
7
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
1135
57
51
43
31
29
22
2
1
Toolboxes
1737
80
62
48
36
35
31
30
20
18
17
11
11
11
10
9
8
8
8
4
3
3
La promoción del lavado de manos es fundamental para minimizar la transmisión de SARS-COV-2 y para salvar vidas. Una de las maneras más frecuentes de trasmisión de SARS-COV-2 es a través de man
...
A recent study informed that ivermectin was successfully used in vitro for the treatment of SARS-CoV-2 in experimentally infected cells and two preprint publications on observational clinical studies reported the apparent utility of ivermectin to tr
...
ESTUDIO ENE-COVID19: Segunda Ronda del Estudio Nacional de Sero-Epidemiología de la Infección por SARS-CoV-2 en España; Informe preliminar 3 de Junio de 2020 Informe nº 33. Análisis de los casos de COVID-19 notificados a la RENAVE hasta el 10 d
...
Non-pharmaceutical interventions (NPI) are public health measures that aim to prevent and/or control SARS-CoV-2 transmission in the community. As long as there is no effective and safe vaccine to protect those at risk of severe COVID-19, NPI are the
...
La promoción del lavado de manos es fundamental para minimizar la transmisión de SARS-COV-2 y para salvar vidas. Una de las maneras más frecuentes de trasmisión de SARS-COV-2 es a través de man
...
A Fiocruz tem produzido uma série de materiais informativos sobre a pandemia da doença pelo SARS-CoV-2 (Covid-19). A reprodução do material é livre e gratuita. Baixe e compartilhe informação correta e de qualidade.
CONVIDECIA is based on a modified human adenovirus that expresses the spike S protein of SARS-CoV-2. It is administered as a single dose.
Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths of 22% and 12%, respectively. In the last 28 days (5 December 2022 to 1 January 2023), over 14.5 million cases and ov
...
The ICMR type 1 diabetes guidelines come at a time when the SARS-CoV-2 pandemic
has disproportionately affected people with diabetes population, exposing them to a
high risk for severe illness and mortality. Globally, diabetes was responsible for
...
Planning and preparedness are the keys to dealing effectively with threats that include infectious diseases caused by SARS and the Middle East Respiratory Syndrome or MERS, novel influenza viruses like H1N1, and Ebola. During outbreaks or epidemics
...
Das Tragen von Mund-Nasen-Bedeckungen kann neben anderen Maßnahmen nach aktuellem Wissensstand helfen, die Verbreitung des Coronavirus SARS-CoV-2 weiter einzudämmen – auch wenn keine Krankheitszeichen vorliegen. Dieses Merkblatt informiert über
...
Coronavirus disease 2019 (COVID-19) is an acute infectious respiratory disease caused by a newly discovered coronavirus (SARS-CoV-2).
Most people infected with the COVID-19 virus experience mild to moderate respiratory illness and recover without
...
Evidencias COVID-19 es un recurso que ofrece información relevante relacionada con la pandemia del coronavirus SARS-CoV-2 y la COVID-19.
Este recurso recoge una serie de documentos que sintetizan la información más relevante para dar respuesta
...
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 immunity from
...
Esta é a primeira edição de orientações sobre estratégias de prevenção e controle de infecção (PCI) para utilizar quando houver suspeita de infecção por um novo coronavírus (2019-nCoV). Foi adaptado do guia da OMS de Prevenção e controle de infecções durante os cuidados de saúde pa
...
Esta é a primeira edição da orientação sobre estratégias de prevenção e controle de infecções (PCI) que devem ser aplicadas quando houver suspeita de COVID-19. Ela foi adaptada do documento da OMS sobre prevenção e controle de infecções durante prestação de cuidados de saúde para ca
...
Dieser Leitfaden zum Management von COVID-19 Ausbruechen richtet sich in erster Linie an die Fachöffentlichkeit im Gesundheitswesen, insbesondere den ÖGD auf allen Ebenen. Er verweist auf viele bereits existierende generische sowie für COVID-19 entwickelten Dokumente. Diese Empfehlungen sind alle
...
Nested case-control study of health workers exposed to confirmed COVID-19 patients.
Similar objectives to the cohort study but case-control studies may be cheaper and provide robust evidence to characterize and assess the risk factors for SARS-CoV-
...
Letzte Aktualisierung: 19.06.2020
Krebspatientinnen und Krebspatienten sind nach Aussage der Experten durch das neuartige Coronavirus (SARS-CoV-2) besonders gefährdet.
Viele Betroffene sind nun sehr verunsichert: Wie wirkt sich das Virus
...
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
